Fangsheng Green Chemical Pharmaceutical

Hunan Fangsheng Green Chemical Pharmaceutical Co., Ltd. is a specialized subsidiary of the publicly traded Hunan Fangsheng Pharmaceutical Co., Ltd., focusing on the research, development, and manufacturing of high-end active pharmaceutical ingredients (APIs) and advanced chemical intermediates. The company is distinguished by its commitment to green chemistry principles, utilizing innovative synthetic routes to minimize environmental impact and improve production efficiency. Its product portfolio primarily serves therapeutic areas such as cardiovascular health, diabetes management, and anti-infectives, with key products including Rivaroxaban and Sitagliptin. Based in Changsha, China, the company operates state-of-the-art, GMP-compliant facilities designed to meet both domestic and international regulatory standards. As a critical component of its parent company's vertically integrated business model, it provides high-quality raw materials for finished dosage forms and offers contract manufacturing services to global partners. The company continues to invest in R&D to expand its pipeline of complex small molecule APIs.